ELAVL1 and cervical carcinoma: Xu et al. uncovered that BBOX1-AS1 expression was elevated in cervical cancer, and BBOX1-AS1 could drive cell malignant phenotypes by up-regulating HOXC6 via miR-361-3p and HuR [17].